קארין 250

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

CLARITHROMYCIN

Commercializzato da:

UNIPHARM LTD, ISRAEL

Codice ATC:

J01FA09

Forma farmaceutica:

טבליות מצופות

Composizione:

CLARITHROMYCIN 250 MG

Via di somministrazione:

פומי

Tipo di ricetta:

מרשם נדרש

Prodotto da:

TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD, ISRAEL

Gruppo terapeutico:

CLARITHROMYCIN

Area terapeutica:

CLARITHROMYCIN

Indicazioni terapeutiche:

Karin is indicated in the treatment of infections caused by one or more susceptible organisms. Lower respiratory tract infections for example, acute and chronic bronchitis, and pneumonia. Upper respiratory tract infections for example, sinusitis and pharyngitis. Karin is also indicated in skin and soft tissue infections of mild to moderate severity. Karin is also indicated in combination with proton pump inhibitor for the eradication of H.pylori in patients with proven duodenal ulcers.

Data dell'autorizzazione:

2012-03-31